Skip to main
VKTX
VKTX logo

Viking Therapeutics (VKTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Viking Therapeutics (VKTX) Stock

About Viking Therapeutics (VKTX)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Market cap$2.98B
Yesterday's volume5.47K
Revenue (TTM)
Avg. daily volume3.94M
EBITDA (TTM)-$171.93M
Open$27.20
Price / earnings ratio-23.01x
Yesterday's range$26.48 - $28.2
Debt / equity0.12x
52 week range$18.92 - $81.73
5 year debt / equity0.24x
Beta (LTM)1.68x
Interest coverage-1605.54x
Dividend & yield$0.00 (0.00%)
Current ratio44.25x
Ex-dividend date
Next earningsJul 23, 2025
Dividend payable date

Viking Therapeutics Stock Rating

What analysts recommend for VKTX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 55%
Buy 36%
Hold 9%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for VKTX stock is $2.98B

The current P/E ratio for VKTX stock is -23.01

The 52-week high for VKTX stock is $81.73. The current VKTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for VKTX stock is $18.92. The current VKTX stock price $undefined has increased 100.00% from its 52-week low

No, the VKTX stock does not pay dividends to its shareholders

The target price for VKTX stock is $70.23 based on the average of what a group of analyst think VKTX stock could be worth at a future date. This is not a prediction by Public.com

How to buy VKTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VKTX stock

    Navigate to the Explore page. Then, type VKTX into the search bar. When you see VKTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VKTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Viking Therapeutics Stock Earnings

The value each VKTX share was expected to gain vs. the value that each VKTX share actually gained.

Viking Therapeutics (VKTX) reported Q1 2025 earnings per share (EPS) of -$0.41, missing estimates of -$0.31 by 32.26%. In the same quarter last year, Viking Therapeutics's earnings per share (EPS) was -$0.26. Viking Therapeutics is expected to release next earnings on 07/23/2025, with an earnings per share (EPS) estimate of -$0.44.

Buy Viking Therapeutics (VKTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.